BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Yang G, Nie P, Fu J, Wang X, Liu D. Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. PLoS One 2013;8:e74327. [PMID: 23977399 DOI: 10.1371/journal.pone.0074327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Pascale F, Pelage JP, Wassef M, Ghegediban SH, Saint-Maurice JP, De Baere T, Denys A, Duran R, Deschamps F, Pellerin O, Maeda N, Laurent A, Namur J. Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics. Front Oncol 2022;12:871829. [PMID: 35619923 DOI: 10.3389/fonc.2022.871829] [Reference Citation Analysis]
2 Liao R, Tang Z, Li X, Lv L, Yang C, Xiong H, Zhou B, Yu J, Zhang D. Proton Magnetic Resonance Spectroscopy at 3.0T in Rabbit With VX2 Liver Cancer: Diagnostic Efficacy and Correlations With Tumor Size. Front Oncol 2022;12:846308. [DOI: 10.3389/fonc.2022.846308] [Reference Citation Analysis]
3 Lv P, Liu J, Yan X, Chai Y, Chen Y, Gao J, Pan Y, Li S, Guo H, Zhou Y. CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours. Eur Radiol 2017;27:918-26. [PMID: 27287476 DOI: 10.1007/s00330-016-4458-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
4 Chen Z, Kang Z, Xiao EH, Tong M, Xiao YD, Li HB. Comparison of two different laparotomy methods for modeling rabbit VX2 hepatocarcinoma. World J Gastroenterol 2015; 21(16): 4875-4882 [PMID: 25945000 DOI: 10.3748/wjg.v21.i16.4875] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Liang Y, Feng Q, Hong J, Feng F, Sang Y, Hu W, Xu M, Peng R, Kang T, Bei J, Zeng Y. Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cells. Front Med 2015;9:57-62. [DOI: 10.1007/s11684-015-0389-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Kong W, Yuan H, Cai H, Wang W, Tang Y, Zhang X. Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound. Tumor Biol 2015;36:2593-9. [DOI: 10.1007/s13277-014-2877-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]